CRO

Enabling More Predictable
CRO Delivery

CROs are expected to accelerate timelines while maintaining regulatory oversight across increasingly complex, multi-study portfolios. Yet visibility alone does not ensure predictable execution.

Talk to Experts

How Maxis AI Works

Maxis AI delivers AI-enabled CRO delivery services through supervised intelligent execution aligned to regulated environments

Study Startup Support

Accelerated study startup with protocol-aware IRB and site activation workflows

Clinical Data Management

Unified clinical data review and risk-based quality management (RBQM) execution

Statistical Programming Support

Predictive risk detection with autonomous investigation

Operational Oversight

Real-time operational visibility across sites, studies, and portfolios

AI-guided early-phase execution

AI-guided early-phase execution

Unlike analytics platforms that surface risk, Maxis AI executes defined operational workflows under human-in-the-loop validation and audit traceability improving delivery consistency while preserving governance.

Who This is Built for

Maxis AI delivers AI-enabled CRO delivery services through supervised intelligent execution aligned to regulated environments

COOs/Heads of Clinical Delivery

Improve predictability and scale delivery models

VPs of Clinical Operations

Reduce startup delays and enrollment risk.

CFOs

Improve cost control and margins.

Biometrics Leaders

Increase execution consistency across data review and submission-readiness workflows.

Where CRO Delivery Often Slows

CRO teams often face recurring friction points that limit predictability:

Prolonged IRB drafting and revision cycles

Fragmented oversight across EDC, CTMS, and eTMF systems

Reactive risk detection after milestone slippage

Escalation-heavy coordination across sponsors and sites

Enrollment forecasting variability

The constraint is not effort, it is scalable execution capacity and orchestration.

What Improves with AI-Led Delivery

With agentic AI for CRO services, execution becomes earlier, structured, and governed:

Compressed startup timelines

Standardized IRB and submission coordination

Proactive risk signal identification

Reduced manual follow-up and escalation dependency

Consistent audit traceability across workflows

Improved milestone predictability across portfolios

Phase 1 Trial: First Patient In <100 Days. Under $400K.

Proof-of-concept delivered in 9–12 months at under $400K versus $2–5M traditional CRO cost — one team, one contract.

<100

First patient in

45%

2–3x

Enrollment conversion

50%

FAQ

All You Need to Know

How does agentic AI improve CRO delivery predictability?

By embedding supervised execution within startup, data review, and risk workflows—enabling earlier detection and structured intervention.

Will this disrupt existing workflows?

No. Maxis AI integrates as a governed execution layer within current clinical platforms.

Does this replace clinical teams?

No. It reduces coordination burden while preserving expert oversight.

Where do CROs typically see impact first?

Predictability in enrollment, faster response speed, and improved forecast confidence.

Is this suitable for multi-study portfolios?

Yes. Throughput and predictability gains compound as complexity increases.

Looking for Agentic AI for clinical trials?

Explore our Agentic AI Platform to see how AI agents are transforming study startup, data management, oversight, and regulatory submissions.

Explore Agentic AI Platform